Article
The Genotype of the Donor for the (GT)n Polymorphism in the Promoter/Enhancer of FOXP3 Is Associated with the Development of Severe Acute GVHD but Does Not Affect the GVL Effect after Myeloablative HLA-Identical Allogeneic Stem Cell Transplantation.
PloS one - 1 Jan 2015
Noriega Víctor, Martínez-Laperche Carolina, Buces Elena, Pion Marjorie, Sánchez-Hernández Noemí, Martín-Antonio Beatriz, Guillem Vicent, Bosch-Vizcaya Anna, Bento Leyre, González-Rivera Milagros, Balsalobre Pascual, Kwon Mi, Serrano David, Gayoso Jorge, de la Cámara Rafael, Brunet Salut, Rojas-Contreras Rafael, Nieto José B, Martínez Carmen, Gónzalez Marcos, Espigado Ildefonso, Vallejo Juan C, Sampol Antonia, Jiménez-Velasco Antonio, Urbano-Ispizua Alvaro, Solano Carlos, Gallardo David, Díez-Martín José L, Buño Ismael
Abstract excerpt
The FOXP3 gene encodes for a protein (Foxp3) involved in the development and functional activity of regulatory T cells (CD4+/CD25+/Foxp3+), which exert regulatory and suppressive roles over the immune system. After allogeneic stem cell transplantation, regulatory T cells are known to mitigate graft versus host disease while probably maintaining a graft versus leukemia effect. Short alleles (≤(GT)15) for the (GT)n...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
